RAB23 and carcinoma: As SHH signaling has been shown to be tumorigenic in various cancer types such as small cell lung cancer, colorectal adenocarcinoma, basal cell carcinoma, and even SCC itself, Rab23 was recognized as a negative regulator of carcinoma.